dimanche 15 novembre 2026
RechercherExplore
fr.via.news
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· May 16, 2026

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

View original at globenewswire.com
Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00 MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after the project announced that it has finalized its Tier-1 exchange shortlist while Stage 16 continues at $0.01717 per token…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • AlphaPepe has finalized its Tier-1 exchange shortlist ahead of a planned Q2 2026 exchange debut

    60% confidence

  • AlphaSwap AI DEX demo has surpassed 4,000 active users

    60% confidence

  • AlphaPepe presale has raised over $1.22 million with more than 8,600 holders

    60% confidence

  • AlphaPepe presale Stage 16 is live at $0.01717 per token

    60% confidence

  • AlphaPepe token delivery is instant with no vesting and no claim delay

    60% confidence

  • XRP could reach $5.00 if regulatory clarity improves, ETF inflows scale into the multi-billion-dollar range, and broader market strength supports large-cap crypto assets

    60% confidence

  • XRP reaching $5.00 depends on CLARITY Act progress, ETF inflows scaling into the multi-billion-dollar range, institutional demand, and broader market strength

    60% confidence

  • AlphaPepe completed a full 10/10 BlockSAFU security audit

    60% confidence

  • AlphaSwap's AI contract screening layer is designed to detect risky token behavior before users interact with a smart contract

    60% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00: Source | Via News | fr.via.news